A multimodal fusion system predicting survival benefits of immune checkpoint inhibitors in unresectable hepatocellular carcinoma
Abstract Early identification of unresectable hepatocellular carcinoma (HCC) patients who may benefit from immune checkpoint inhibitors (ICIs) is crucial for optimizing outcomes. Here, we developed a multimodal fusion (MMF) system integrating CT-derived deep learning features and clinical data to pr...
Saved in:
| Main Authors: | Jun Xu, Tengfei Wang, Junjun Li, Yong Wang, Zhangxiang Zhu, Xiao Fu, Junjie Wang, Zhenglin Zhang, Wei Cai, Ruipeng Song, Changlong Hou, Li-Zhuang Yang, Hongzhi Wang, Stephen T. C. Wong, Hai Li |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-06-01
|
| Series: | npj Precision Oncology |
| Online Access: | https://doi.org/10.1038/s41698-025-00979-6 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Role of immune checkpoint inhibitor combinations in resectable and unresectable, embolization-eligible hepatocellular carcinoma
by: Brandon M. Meyers, et al.
Published: (2025-07-01) -
Prediction of prognosis of immune checkpoint inhibitors combined with anti-angiogenic agents for unresectable hepatocellular carcinoma by machine learning-based radiomics
by: Xuni Xu, et al.
Published: (2025-05-01) -
Deep learning of pretreatment multiphase CT images for predicting response to lenvatinib and immune checkpoint inhibitors in unresectable hepatocellular carcinoma
by: Nan-Qing Liao, et al.
Published: (2024-12-01) -
Safety and efficacy of TACE combined with immune checkpoint inhibitors plus molecular targeted therapies in older adults with unresectable hepatocellular carcinoma
by: Xin Hong, et al.
Published: (2025-07-01) -
Enhanced efficacy of immune checkpoint inhibitors combined locoregional therapy and tyrosine kinase inhibitors in the treatment of unresectable hepatocellular carcinoma: A single - center retrospective study
by: Junfeng Bu, et al.
Published: (2025-02-01)